Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

This study has been terminated.
(organizational reasons at sites: low recruitment)
Sponsor:
Information provided by:
B. Braun Melsungen AG
ClinicalTrials.gov Identifier:
NCT00936247
First received: July 8, 2009
Last updated: September 27, 2010
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)